7NT4
X-ray structure of SCoV2-PLpro in complex with small molecule inhibitor
Summary for 7NT4
Entry DOI | 10.2210/pdb7nt4/pdb |
Descriptor | Non-structural protein 3, PROFLAVIN, 1,2-ETHANEDIOL, ... (6 entities in total) |
Functional Keywords | drug repurposing, scov2-plpro inhibitor, hydrolase |
Biological source | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV, SARS-CoV-2) |
Total number of polymer chains | 2 |
Total formula weight | 74162.75 |
Authors | Napolitano, V.,Mourao, A.,Bostock, M.,Matsuda, A.,Czarna, A.,Popowicz, G.M. (deposition date: 2021-03-09, release date: 2022-02-02, Last modification date: 2024-01-31) |
Primary citation | Napolitano, V.,Dabrowska, A.,Schorpp, K.,Mourao, A.,Barreto-Duran, E.,Benedyk, M.,Botwina, P.,Brandner, S.,Bostock, M.,Chykunova, Y.,Czarna, A.,Dubin, G.,Frohlich, T.,Holscher, M.,Jedrysik, M.,Matsuda, A.,Owczarek, K.,Pachota, M.,Plettenburg, O.,Potempa, J.,Rothenaigner, I.,Schlauderer, F.,Slysz, K.,Szczepanski, A.,Greve-Isdahl Mohn, K.,Blomberg, B.,Sattler, M.,Hadian, K.,Popowicz, G.M.,Pyrc, K. Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronaviruses. Cell Chem Biol, 29:774-, 2022 Cited by PubMed: 35021060DOI: 10.1016/j.chembiol.2021.11.006 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.68 Å) |
Structure validation
Download full validation report